Ke Xu

10PUBLICATIONS
4CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 15, 2025
Efficacy and safety of EGFR monoclonal antibody combined with gemcitabine-based chemotherapy in first-line treatment of locally advanced unresectable or metastatic pancreatic cancer.

Yan Feng, Ya Feng, Ke Xu

|Aug 27, 2025
Development and Validation of a Clinlabomics-Based Nomogram for Predicting the Prognosis of Small Cell Lung Cancer in China: A Multicenter, Retrospective Cohort Study.

Qi Peng, Fang Yang, Ke Xu

|Apr 02, 2025
Systematic exploration of prognostic alternative splicing events related to tumor immune microenvironment of Clear Cell Renal Cell Carcinoma.

Hongwei Wu, Yuchuan Zhou, Xi Wang

|Nov 11, 2024
Plasma COL10A1 Level, a Potential Diagnostic and Prognostic Biomarker for Pancreatic Ductal Adenocarcinoma.

Tianlei Wang, Xinrui Bao, Fang Yang

|Nov 04, 2024
Efficacy and toxicity of lurbinectedin in subsequent systemic therapy of extensive-stage small cell lung cancer: a meta-analysis.

Jiayi Tang, Tianlei Wang, Hongwei Wu

|Nov 11, 2023
Efficacy and toxicity of drugs targeting KRASG12C mutation in non-small cell lung cancer: a meta-analysis.

Wei Luo, Jing Zhu, Wenxue Zhang

Pageof 2

Frequent Collaborators

1 joint publications

Jie He

1 joint publications

Fang Yang

1 joint publications

Qi Peng

1 joint publications

Huaichao Luo